NeurogesX Receives Determination Letter From NASDAQ – MarketWatch (press release)
|
NeurogesX Receives Determination Letter From NASDAQ
MarketWatch (press release) SAN MATEO, Calif., Apr 20, 2012 (GlobeNewswire via COMTEX) — NeurogesX, Inc. (NASDAQ:NGSX) , a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies, today announced that … NeurogesX Receives Letter From Nasdaq For Non-Compliance With Listing Rule NeurogesX Receives Determination Letter From NASDAQ; Not Regaining Compliance |
